An expert opinion on safinamide in Parkinson's disease-Reference-Cited by-同舟云学术

An expert opinion on safinamide in Parkinson's disease

Published:2008-06-12 Issue:7 Volume:17 Page:1115-1125
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Onofrj Marco¹,Bonanni Laura¹,Thomas Astrid¹

Affiliation:

1. University G D'Annunzio of Chieti-Pescara, University Foundation ‘G D'Annunzio’, Department of Oncology and Neuroscience, Ageing Research Center, CeSI, via Colle Dell'Ara 31, 66013 Chieti-Scalo, Italy ; ;

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1517/13543784.17.7.1115

Reference60 articles.

1. Epidemiology of parkinsonism: Incidence, classification, and mortality

2. Blockade of glutamatergic transmission as treatment for dyskinesias and motor fluctuations in Parkinson's disease

3. Sudden appearence of invalidating dyskinesia-dystonia and off fluctuations after the introduction of levodopa in two dopaminomimetic drug naive patients with stage IV Parkinson's disease

4. Motor fluctuations and dyskinesias in Parkinson's disease: Clinical manifestations

5. Neuroprotective agents for clinical trials in Parkinson's disease: A systematic assessment

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functional efficacy of the MAO-B inhibitor safinamide in murine substantia nigrapars compactadopaminergic neuronsin vitro: a comparative study with tranylcypromine;2024-06-01

2. The Effects of Safinamide in Chinese and Non-Chinese Patients with Parkinson’s Disease;Advances in Therapy;2023-12-09

3. The effects of safinamide according to gender in Chinese parkinsonian patients;Scientific Reports;2023-11-23

4. Efficacy and Safety of MAO-B Inhibitors Safinamide and Zonisamide in Parkinson’s Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;CNS Drugs;2023-11

5. Real world data of a German Parkinson’s disease population: effectiveness and safety of safinamide in routine clinical practice;Current Medical Research and Opinion;2023-07-17